Join the @MAD_ID_ASP Communications Committee in reviewing data related to current IDSA guidance on the treatment of AmpC-producing Enterobacterales, which suggests carbapenem therapy over cefepime for serious infections caused by E. cloacae, K. aerogenes or C. freundii with a cefepime MIC of 4-8 mg/L. Thank you for tuning in!
References:
Tamma et al. pubmed.ncbi.nlm.nih.gov/34864936/
Roos et al. pubmed.ncbi.nlm.nih.gov/16943209/
Maglio et al. pubmed.ncbi.nlm.nih.gov/15155182/
Lee et al. ncbi.nlm.nih.gov/pmc/articles/PMC4649147/
Kunz Coyne et al. academic.oup.com/ofid/article/10/3/ofad034/7005372
